Search for: "Michael Lamb" Results 41 - 60 of 263
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Nov 2011, 12:18 pm by Tom Lamb
On the other side of this drug safety debate was Michael Nauck, MD, of the Diabetes Center Bad Lauterberg in Harz, Germany. [read post]
29 Jan 2008, 3:13 pm
The panel also authorized a subpoena to Health and Human Services [(HHS)] Secretary Michael O. [read post]
1 Mar 2013, 8:00 am
March comes in like a lion and out like a lamb. [read post]
6 May 2009, 3:01 pm
May 12 Hearing In Washington Begins The Debate About Whether The Medical Device Industry Should Have Total Immunity From Legal Liability (Posted by Tom Lamb at DrugInjuryWatch.com) On May 12, 2009 the Health Subcommittee of the House Energy and Commerce Committee will have a hearing on the Medical Device Safety Act of 2009. [read post]
13 May 2022, 1:47 am
"But even a humble loaf of sourdough requires the equivalent of about 5.5 tablespoons of diesel fuel, and a supermarket tomato, which Smil describes as no more than 'an appealingly shaped container of water'... is the product of about six tablespoons of diesel. 'How many vegans enjoying the salad,' he writes, 'are aware of its substantial fossil fuel pedigree? [read post]
5 Sep 2012, 10:12 am by David Lat
Continue reading »Follow Above the Law on Twitter or become a fan on Facebook.Tags: Biglaw, David Lane, Dewey & LeBoeuf, Greenspoon Marder, Job Searches, Joel Sanders, Kathryn Bates, Lateral Hiring, Lateral Moves, Laterals, LeBoeuf Lamb, Michael E. [read post]
16 Sep 2011, 2:24 pm by Tom Lamb
Michael Carome, deputy director of Public Citizen's Health Research Group in Washington, D.C.: Patients need to be aware that almost any drug has potential side effects," he said. [read post]
21 Oct 2008, 1:14 am
A lot of different stuff out in the LexBlogosphere today, including a very insightful post by Michael Moore, who offers an employer's guide to the upcoming election. [read post]
5 Sep 2014, 1:15 pm by Tom Lamb
First, the Feature items: Dabigatran: how the drug company withheld important analysesDeborah Cohen Concerns over data in key dabigatran trialDeborah Cohen Next, the Analysis item: Dabigatran, bleeding, and the regulatorsThomas J Moore, Michael R Cohen, and Donald R Mattison And finally, the Editorial item: The trouble with dabigatranBlake Charlton and Rita Redberg We will continue to monitor the safety profiles of Eliquis and Xarelto as well as watch to see whether drug injury and death… [read post]